Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Single-Cell Omics Market CAGR Outlook And Future Development
The single-cell omics market has shown significant growth recently. It is anticipated to increase from $2.39 billion in 2025 to $2.78 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.3%. Key drivers of past growth include advancements in next-generation sequencing, increased academic research funding, expanding cancer research initiatives, the demand for cellular heterogeneity analysis, and improvements in cell isolation technologies.
The single-cell omics market is projected to experience substantial expansion over the upcoming years. It is forecast to reach $5.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This growth throughout the forecast period stems from factors such as the expansion of precision medicine initiatives, the incorporation of artificial intelligence into omics analysis, a rise in pharmaceutical research and development investments, increasing use in clinical diagnostics, and the creation of more affordable single-cell platforms. Key trends identified for this period encompass a growing uptake of multi-omics methodologies, an increasing requirement for high-resolution cellular examination, the broadening of single-cell applications in oncology studies, enhanced utilization of microfluidics for isolating cells, and the establishment of standardized procedures for single-cell analysis.
Get A Free Sample Report With In-Depth Market Insights:
Single-Cell Omics Market Expansion Drivers: What’s Shaping Future Growth?
The increasing incidence of cancer is anticipated to drive the expansion of the single-cell omics market in the future. Cancer refers to a group of diseases that can emerge in almost any bodily organ or tissue when abnormal cells multiply without control, extend beyond their typical limits, and either metastasize to other organs or infiltrate adjacent body parts. Single-cell omics data has been extensively utilized for identifying biomarkers for cancer diagnosis, predicting prognosis, and uncovering new therapeutic targets within specific clinical cohorts. For example, the National Institutes of Health, a US-based government agency, reported in May 2024 that around 18.1 million people in the United States were living as cancer survivors as of January 2022. This figure is projected to increase to 22.5 million by 2032. Consequently, the growing occurrence of cancer is fueling the growth of the single-cell omics market.
Single-Cell Omics Market Segment Performance And Emerging Opportunities
The single-cell omics market covered in this report is segmented –
1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing
3) By Application: Oncology, Cell Biology, Neurology, Immunology
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits
2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits
3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits
4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits
Single-Cell Omics Market Strategic Trends: What Defines The Next Growth Phase?
Leading entities within the single-cell omics market prioritize the creation of sophisticated kits, notably sequencing kits, for use in single-cell applications, aiming to boost their earnings within the sector. These sequencing kits represent pre-assembled collections of reagents and other necessary items crafted for genetic sequencing procedures, thus simplifying laboratory operations. An illustrative example occurred in February 2023 when Singular Genomics Systems, Inc., a US firm utilizing innovative next-generation sequencing (NGS) technology, introduced its Max Read Kits for single-cell sequencing on its G4 Sequencing Platform. The Max Read Kits are engineered to be compatible with widely used 10x Genomics assays and provide the versatility to sequence between 4 and 16 samples in each run. Each flow cell using these kits delivers 800 million reads, maintaining a Q30 quality of 80% to 90%. Additionally, Singular Genomics improves the quality specifications for the F2 and F3 flow cells of the G4 Sequencing Platform, reaching as many as 1.8 billion reads per run on the F3 flow cells for specific applications.
Single-Cell Omics Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the single-cell omics market are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Sartorius AG, Illumina Inc, Bio Rad Laboratories Inc, Qiagen NV, Tecan Group Ltd, BGI Genomics Co Ltd, 10x Genomics Inc, Takara Bio Inc, NanoString Technologies Inc, Vizgen, Deepcell, Mission Bio Inc, Standard BioTools Inc, CYTENA GmbH, Single Cell Discoveries
View The Full Single-Cell Omics Market Report:
Single-Cell Omics Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the single-cell omics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
